The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases
Cell Proliferation · 2025-08 · 58 (8)
DOI: 10.1111/cpr.13804 ↗At a glance
Übersichtsarbeit in Cell Proliferation, published online on 2025-02-11. Written by Lian Jin and 4 co-authors. Institution: Hunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou, Hunan, People's Republic of China. Major MEDLINE topics: Nanoparticles, Neurodegenerative Diseases, Polymers, Drug Carriers. Cited 24 times so far (Crossref); 165 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (original language)
In spite of great advances in modern medicine, there are a few effective strategies for the treatment of neurodegenerative diseases characterised by neuron loss or degeneration. This results from complex pathogenesis of the diseases and the limited drug uptake of the brain due to the presence of blood‐brain barrier. Nanoparticle‐based drug delivery systems are expected to improve the drug utilisation. Polymeric nanoparticles represent promising drug delivery carriers to the brain due to their unique advantages such as good biodegradability and biocompatibility, flexibility in surface modification and nontoxicity. In addition, the delivery of genetic drugs may stop the progression of neurodegenerative diseases at the genetic level and even avoid the irreversible damage in the central nervous system. In this review, an overview of studies on polymer‐based nanoparticles for drug delivery to the central nervous system in typical neurodegenerative diseases, especially Alzheimer's diseases and Parkinson's diseases, is described. Meanwhile, their applications in gene delivery in these disorders are discussed. And the challenges and future perspectives for the development of polymeric nanoparticles as drug delivery carriers in neurodegenerative diseases are concluded.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Hunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou, Hunan, People's Republic of China.
- Shenzhen Feidu Biomedicine Co. Ltd., Shenzhen, China.
- Institute for Future Sciences, University of South China, Changsha, China.
- Institute of Cytology and Genetics, School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang, China.
- Faculty of Pharmaceutical Sciences, University of Central Punjab, Lahore, Pakistan.
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
ORCID profiles: Lian Jin
Funding
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Cite
APA
Jin, L., Nie, L., Deng, Y., Khana, G. J., & He, N. (2025). The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases. Cell Proliferation, 58(8). https://doi.org/10.1111/cpr.13804
Vancouver
Jin L, Nie L, Deng Y, Khana GJ, He N. The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases. Cell Proliferation. 2025;58(8). doi:10.1111/cpr.13804
BibTeX
@article{Jin2025,
author = {Jin, Lian and Nie, Libo and Deng, Yan and Khana, Ghulam Jilany and He, Nongyue},
title = {The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases},
journal = {Cell Proliferation},
year = {2025},
volume = {58},
number = {8},
doi = {10.1111/cpr.13804}
}
EUVIMED